Cunivak RHD
Cunivak RHD
Not authorised
- Rabbit haemorrhagic disease virus, Inactivated
Product identification
Medicine name:
Cunivak RHD
Active substance:
- Rabbit haemorrhagic disease virus, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabbit haemorrhagic disease virus, Inactivated2048.00/haemagglutinating units1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Rabbit
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Rabbit
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Tiergesundheit (Riems) GmbH
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 206a/92
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/03/2022
Updated on: 14/03/2026